Post Reply
7101-7120 of 10899
Greetings Bengster and fellow forum mates. I cannot see the pictures you posted. Maybe something with my PC. Yes I feel sad that with so much news and 'potential', there is any positive movement with Biosensor share price. I have been fully committed and remain hopeful for better days to come. In one scenario, a target price of $3.00 and cash holding of US$250M was mentioned. And/or if this cash holding of US$250M is not achievable and remain at US$100M [as currently], a share price of between $2.20 to $2.50 was also mentioned. All these subject to good LEADERS results. I hope that with good LEADERS results later in the year, either way, Biosensor should seek a takeover even at $2.20. For those invested, it is already a lot of money. But for Biosensor, in the field of the big boy game, it is a struggle if they do not seek alliance, one way or another. Also, in Singapore we can hardly find any good stock analyst unlike the more matured markets. MOST of our analyst are KKK = Kiasu, Kiabor and Kiasee. Cheers
Hi Bengster, thanks for the insightful info. Just wondering, if BIG wanna shows they are serious in matching up with the big guys, they could try to raise cash thru bank loans, right issues or convertible bonds. In that case, they will still get the 'royalties' while showing that they can become potential powerhouse, no?
I maintain my stand that takeover will happen at end 2008 after LEADERS trial. If BIG can secure at least US$250m cash before LEADERS trial, takeover offer price will be at least $3 and nothing less. If BIG has only US$100m cash like now (previous even more jia lat at only US$60m cash before the US$40m cash announcement), takeover offer price may drop drastically to $2.20 to $2.50 due to the lack of "FEAR FACTOR" that BIG is just a toothless and clawless tiger. So what if BIG has top-class DES technology? BIG cannot fully exploit their technology on a global basis if they don't have enough money to fund their global expansion and BIG will just remain as a small player with small global market share. In such a case, BIG is of not much threat to the DES rivals and they will not offer BIG good takeover offer price even when these big boys find BIG a very attractive target. It is very important now for BIG to have US$250m cash to show the DES rival big boys that BIG can become global DES powerhouse in BIG's own capacity and don't come and try to squeeze my price. Anything less than US$250m cash position will put BIG at a huge disadvantage position at takeover negotiations.
i thought that BIG is slightly on the losing end for agreeing to the USD40 mil deal as the rewards from the potential revenue sharing component could be much higher... that is at the expense of longer term rewards for increasing their war chest now
Noted.But the other companies are aggressive in their marketing . Hope Biosensors come up with positive results soon . Much as I am sad that XiaoMaGe laughs at us in our face and appears spiteful it is .... Quite frustrating .that he is right... Good news like the usd40m and still no reaction...MUST really be patient and believe in this share. I was hoping the cut in tax on share transaction in China, although not related would have given a boost to Biosensors' share price....
Nevertheless, Bengster we appreciate your in-depth analysis and confidence in the share and I shall perservere!!!
Frankly i dont quite trust what MDT report as they are always misleading and hide ugly short-comings of Endeavor. They always paint a nice picture on their Endeavor performance. The fact is their TLR is higher than Taxus but they insist their TLR is a low figure. Why don't they check out the NOBORI trials of Biomatrix VS Taxus. The TLR of Biomatrix is what i call low and backed by facts for all to see. Taxus is the same DES that Biomatrix and Endeavor both had RCT. So it is a fair comparison to judge which DES is more superior using performance against Taxus as a benchmark.
Not good Not Bad news..
XiaoMaGe888 ( Date: 25-Apr-2008 09:12) Posted:
|
Good or bad news price still down.
40 million good news or not?
allright ( Date: 25-Apr-2008 08:11) Posted:
Is this good news for Biosensors?
Endeavor Zotarolimus-Eluting Coronary Stent System
Clinical Updates from ACC'08
Safety Delivered:
Endeavor DES clinical programs have more than 1200 patients followed to
3 years
No new events in a doubling of patients out to 3 years (ARC
definite/probable stent thrombosis).
Efficacy Proven:
Low rates of target lesion revascularization (TLR) across a variety of
high-risk subgroups of patients. |
|
|
|
Good or bad news price still down.
40 million good news or not?
allright ( Date: 25-Apr-2008 08:11) Posted:
Is this good news for Biosensors?
Endeavor Zotarolimus-Eluting Coronary Stent System
Clinical Updates from ACC'08
Safety Delivered:
Endeavor DES clinical programs have more than 1200 patients followed to
3 years
No new events in a doubling of patients out to 3 years (ARC
definite/probable stent thrombosis).
Efficacy Proven:
Low rates of target lesion revascularization (TLR) across a variety of
high-risk subgroups of patients. |
|
Is this good news for Biosensors?
Endeavor Zotarolimus-Eluting Coronary Stent System
Clinical Updates from ACC'08
Safety Delivered:
Endeavor DES clinical programs have more than 1200 patients followed to
3 years
No new events in a doubling of patients out to 3 years (ARC
definite/probable stent thrombosis).
Efficacy Proven:
Low rates of target lesion revascularization (TLR) across a variety of
high-risk subgroups of patients.
would recommend to take a look only if it closes abv 75c. there is a major resiatnce at 80c
AK opine that, don't look at the price, look forward. Thats what is investment for?????
jackjames ( Date: 24-Apr-2008 22:03) Posted:
|
you know me well...
always remember 50-50 stratergy on this counter !
novena_33 ( Date: 24-Apr-2008 14:46) Posted:
he waiting at 69 lar........ opps... not position .... is cents 
|
|
|
|
you know me well...
always remember 50-50 stratergy on this counter !
novena_33 ( Date: 24-Apr-2008 14:46) Posted:
he waiting at 69 lar........ opps... not position .... is cents
|
|
Ya..but, but oni when closer to reporting time, thing will start changing for better thing to come as China slashed it stamp fee from 0.3 to 0.1%. This stock is more for mid to long term.
AGAIN!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
big seems to be stuck in the 70+cents region...
China cuts stamp duty on share transactions from 0.3pc to 0.1pc to boost stock market..
he waiting at 69 lar........ opps... not position .... is cents
You can buy now!!!!!!!!!!!!!!!!
jackjames ( Date: 24-Apr-2008 10:45) Posted:
| sell to me , sell to me ! |
|
so just hold tight tight..... and put under my pillow...
coatslee.jpg